ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intranasal Drug And Vaccine Delivery Device Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-38U8201
Home | Market Reports | Health| Medical Devices & Equipment
Global and Japan Intranasal Drug And Vaccine Delivery Device Market Insights Forecast to 2027
BUY CHAPTERS

Global Intranasal Drug And Vaccine Delivery Device Market Research Report 2025

Code: QYRE-Auto-38U8201
Report
July 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Teva Pharmaceuticals
Aptar Pharma
UCB
Teleflex
3M
Bespak
OptiNose
Intersect

Intranasal Drug And Vaccine Delivery Device Market Size

The global market for Intranasal Drug And Vaccine Delivery Device was valued at US$ 1246 million in the year 2024 and is projected to reach a revised size of US$ 1666 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Intranasal Drug And Vaccine Delivery Device Market

Intranasal Drug And Vaccine Delivery Device Market

Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intranasal Drug And Vaccine Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intranasal Drug And Vaccine Delivery Device.
The Intranasal Drug And Vaccine Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intranasal Drug And Vaccine Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intranasal Drug And Vaccine Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intranasal Drug And Vaccine Delivery Device Market Report

Report Metric Details
Report Name Intranasal Drug And Vaccine Delivery Device Market
Accounted market size in year US$ 1246 million
Forecasted market size in 2031 US$ 1666 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Powder Delivery Device
  • Liquid Delivery Device
  • Pressurized Metered Dose Inhaler
  • Others
Segment by Application
  • Respiratory Disorders
  • Neurological Disorder
  • Vaccination
  • Pain Management
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Teva Pharmaceuticals, Aptar Pharma, UCB, Teleflex, 3M, Bespak, OptiNose, Intersect
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intranasal Drug And Vaccine Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intranasal Drug And Vaccine Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Intranasal Drug And Vaccine Delivery Device Market growing?

Ans: The Intranasal Drug And Vaccine Delivery Device Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Intranasal Drug And Vaccine Delivery Device Market size in 2031?

Ans: The Intranasal Drug And Vaccine Delivery Device Market size in 2031 will be US$ 1666 million.

Who are the main players in the Intranasal Drug And Vaccine Delivery Device Market report?

Ans: The main players in the Intranasal Drug And Vaccine Delivery Device Market are GlaxoSmithKline, Teva Pharmaceuticals, Aptar Pharma, UCB, Teleflex, 3M, Bespak, OptiNose, Intersect

What are the Application segmentation covered in the Intranasal Drug And Vaccine Delivery Device Market report?

Ans: The Applications covered in the Intranasal Drug And Vaccine Delivery Device Market report are Respiratory Disorders, Neurological Disorder, Vaccination, Pain Management, Others

What are the Type segmentation covered in the Intranasal Drug And Vaccine Delivery Device Market report?

Ans: The Types covered in the Intranasal Drug And Vaccine Delivery Device Market report are Powder Delivery Device, Liquid Delivery Device, Pressurized Metered Dose Inhaler, Others

1 Intranasal Drug And Vaccine Delivery Device Market Overview
1.1 Product Definition
1.2 Intranasal Drug And Vaccine Delivery Device by Type
1.2.1 Global Intranasal Drug And Vaccine Delivery Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder Delivery Device
1.2.3 Liquid Delivery Device
1.2.4 Pressurized Metered Dose Inhaler
1.2.5 Others
1.3 Intranasal Drug And Vaccine Delivery Device by Application
1.3.1 Global Intranasal Drug And Vaccine Delivery Device Market Value by Application (2024 VS 2031)
1.3.2 Respiratory Disorders
1.3.3 Neurological Disorder
1.3.4 Vaccination
1.3.5 Pain Management
1.3.6 Others
1.4 Global Intranasal Drug And Vaccine Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Intranasal Drug And Vaccine Delivery Device Revenue 2020-2031
1.4.2 Global Intranasal Drug And Vaccine Delivery Device Sales 2020-2031
1.4.3 Global Intranasal Drug And Vaccine Delivery Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intranasal Drug And Vaccine Delivery Device Market Competition by Manufacturers
2.1 Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intranasal Drug And Vaccine Delivery Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intranasal Drug And Vaccine Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intranasal Drug And Vaccine Delivery Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intranasal Drug And Vaccine Delivery Device, Product Type & Application
2.7 Global Key Manufacturers of Intranasal Drug And Vaccine Delivery Device, Date of Enter into This Industry
2.8 Global Intranasal Drug And Vaccine Delivery Device Market Competitive Situation and Trends
2.8.1 Global Intranasal Drug And Vaccine Delivery Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intranasal Drug And Vaccine Delivery Device Players Market Share by Revenue
2.8.3 Global Intranasal Drug And Vaccine Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intranasal Drug And Vaccine Delivery Device Market Scenario by Region
3.1 Global Intranasal Drug And Vaccine Delivery Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intranasal Drug And Vaccine Delivery Device Sales by Region: 2020-2031
3.2.1 Global Intranasal Drug And Vaccine Delivery Device Sales by Region: 2020-2025
3.2.2 Global Intranasal Drug And Vaccine Delivery Device Sales by Region: 2026-2031
3.3 Global Intranasal Drug And Vaccine Delivery Device Revenue by Region: 2020-2031
3.3.1 Global Intranasal Drug And Vaccine Delivery Device Revenue by Region: 2020-2025
3.3.2 Global Intranasal Drug And Vaccine Delivery Device Revenue by Region: 2026-2031
3.4 North America Intranasal Drug And Vaccine Delivery Device Market Facts & Figures by Country
3.4.1 North America Intranasal Drug And Vaccine Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intranasal Drug And Vaccine Delivery Device Sales by Country (2020-2031)
3.4.3 North America Intranasal Drug And Vaccine Delivery Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intranasal Drug And Vaccine Delivery Device Market Facts & Figures by Country
3.5.1 Europe Intranasal Drug And Vaccine Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intranasal Drug And Vaccine Delivery Device Sales by Country (2020-2031)
3.5.3 Europe Intranasal Drug And Vaccine Delivery Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intranasal Drug And Vaccine Delivery Device Market Facts & Figures by Region
3.6.1 Asia Pacific Intranasal Drug And Vaccine Delivery Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intranasal Drug And Vaccine Delivery Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Intranasal Drug And Vaccine Delivery Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intranasal Drug And Vaccine Delivery Device Market Facts & Figures by Country
3.7.1 Latin America Intranasal Drug And Vaccine Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intranasal Drug And Vaccine Delivery Device Sales by Country (2020-2031)
3.7.3 Latin America Intranasal Drug And Vaccine Delivery Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intranasal Drug And Vaccine Delivery Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Intranasal Drug And Vaccine Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intranasal Drug And Vaccine Delivery Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intranasal Drug And Vaccine Delivery Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intranasal Drug And Vaccine Delivery Device Sales by Type (2020-2031)
4.1.1 Global Intranasal Drug And Vaccine Delivery Device Sales by Type (2020-2025)
4.1.2 Global Intranasal Drug And Vaccine Delivery Device Sales by Type (2026-2031)
4.1.3 Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Type (2020-2031)
4.2 Global Intranasal Drug And Vaccine Delivery Device Revenue by Type (2020-2031)
4.2.1 Global Intranasal Drug And Vaccine Delivery Device Revenue by Type (2020-2025)
4.2.2 Global Intranasal Drug And Vaccine Delivery Device Revenue by Type (2026-2031)
4.2.3 Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Type (2020-2031)
4.3 Global Intranasal Drug And Vaccine Delivery Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intranasal Drug And Vaccine Delivery Device Sales by Application (2020-2031)
5.1.1 Global Intranasal Drug And Vaccine Delivery Device Sales by Application (2020-2025)
5.1.2 Global Intranasal Drug And Vaccine Delivery Device Sales by Application (2026-2031)
5.1.3 Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Application (2020-2031)
5.2 Global Intranasal Drug And Vaccine Delivery Device Revenue by Application (2020-2031)
5.2.1 Global Intranasal Drug And Vaccine Delivery Device Revenue by Application (2020-2025)
5.2.2 Global Intranasal Drug And Vaccine Delivery Device Revenue by Application (2026-2031)
5.2.3 Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Application (2020-2031)
5.3 Global Intranasal Drug And Vaccine Delivery Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Company Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Pharmaceuticals Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Aptar Pharma
6.3.1 Aptar Pharma Company Information
6.3.2 Aptar Pharma Description and Business Overview
6.3.3 Aptar Pharma Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aptar Pharma Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.3.5 Aptar Pharma Recent Developments/Updates
6.4 UCB
6.4.1 UCB Company Information
6.4.2 UCB Description and Business Overview
6.4.3 UCB Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 UCB Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.4.5 UCB Recent Developments/Updates
6.5 Teleflex
6.5.1 Teleflex Company Information
6.5.2 Teleflex Description and Business Overview
6.5.3 Teleflex Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teleflex Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.5.5 Teleflex Recent Developments/Updates
6.6 3M
6.6.1 3M Company Information
6.6.2 3M Description and Business Overview
6.6.3 3M Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 3M Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 Bespak
6.7.1 Bespak Company Information
6.7.2 Bespak Description and Business Overview
6.7.3 Bespak Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bespak Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.7.5 Bespak Recent Developments/Updates
6.8 OptiNose
6.8.1 OptiNose Company Information
6.8.2 OptiNose Description and Business Overview
6.8.3 OptiNose Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 OptiNose Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.8.5 OptiNose Recent Developments/Updates
6.9 Intersect
6.9.1 Intersect Company Information
6.9.2 Intersect Description and Business Overview
6.9.3 Intersect Intranasal Drug And Vaccine Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Intersect Intranasal Drug And Vaccine Delivery Device Product Portfolio
6.9.5 Intersect Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intranasal Drug And Vaccine Delivery Device Industry Chain Analysis
7.2 Intranasal Drug And Vaccine Delivery Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intranasal Drug And Vaccine Delivery Device Production Mode & Process Analysis
7.4 Intranasal Drug And Vaccine Delivery Device Sales and Marketing
7.4.1 Intranasal Drug And Vaccine Delivery Device Sales Channels
7.4.2 Intranasal Drug And Vaccine Delivery Device Distributors
7.5 Intranasal Drug And Vaccine Delivery Device Customer Analysis
8 Intranasal Drug And Vaccine Delivery Device Market Dynamics
8.1 Intranasal Drug And Vaccine Delivery Device Industry Trends
8.2 Intranasal Drug And Vaccine Delivery Device Market Drivers
8.3 Intranasal Drug And Vaccine Delivery Device Market Challenges
8.4 Intranasal Drug And Vaccine Delivery Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Teva Pharmaceuticals
Aptar Pharma
UCB
Teleflex
3M
Bespak
OptiNose
Intersect
List of Tables
 Table 1. Global Intranasal Drug And Vaccine Delivery Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intranasal Drug And Vaccine Delivery Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intranasal Drug And Vaccine Delivery Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intranasal Drug And Vaccine Delivery Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intranasal Drug And Vaccine Delivery Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intranasal Drug And Vaccine Delivery Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intranasal Drug And Vaccine Delivery Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intranasal Drug And Vaccine Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intranasal Drug And Vaccine Delivery Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intranasal Drug And Vaccine Delivery Device, Product Type & Application
 Table 12. Global Key Manufacturers of Intranasal Drug And Vaccine Delivery Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intranasal Drug And Vaccine Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug And Vaccine Delivery Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intranasal Drug And Vaccine Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intranasal Drug And Vaccine Delivery Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Region (2020-2025)
 Table 19. Global Intranasal Drug And Vaccine Delivery Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Region (2026-2031)
 Table 21. Global Intranasal Drug And Vaccine Delivery Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Intranasal Drug And Vaccine Delivery Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Intranasal Drug And Vaccine Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intranasal Drug And Vaccine Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Intranasal Drug And Vaccine Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Intranasal Drug And Vaccine Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intranasal Drug And Vaccine Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intranasal Drug And Vaccine Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intranasal Drug And Vaccine Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Intranasal Drug And Vaccine Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Intranasal Drug And Vaccine Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intranasal Drug And Vaccine Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intranasal Drug And Vaccine Delivery Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intranasal Drug And Vaccine Delivery Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Intranasal Drug And Vaccine Delivery Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Intranasal Drug And Vaccine Delivery Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intranasal Drug And Vaccine Delivery Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intranasal Drug And Vaccine Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intranasal Drug And Vaccine Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Intranasal Drug And Vaccine Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Intranasal Drug And Vaccine Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intranasal Drug And Vaccine Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intranasal Drug And Vaccine Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intranasal Drug And Vaccine Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Intranasal Drug And Vaccine Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Intranasal Drug And Vaccine Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intranasal Drug And Vaccine Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intranasal Drug And Vaccine Delivery Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Intranasal Drug And Vaccine Delivery Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Type (2020-2025)
 Table 53. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Type (2026-2031)
 Table 54. Global Intranasal Drug And Vaccine Delivery Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intranasal Drug And Vaccine Delivery Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Intranasal Drug And Vaccine Delivery Device Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Intranasal Drug And Vaccine Delivery Device Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Intranasal Drug And Vaccine Delivery Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Intranasal Drug And Vaccine Delivery Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Application (2020-2025)
 Table 63. Global Intranasal Drug And Vaccine Delivery Device Sales Market Share by Application (2026-2031)
 Table 64. Global Intranasal Drug And Vaccine Delivery Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intranasal Drug And Vaccine Delivery Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Intranasal Drug And Vaccine Delivery Device Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Intranasal Drug And Vaccine Delivery Device Price (US$/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Intranasal Drug And Vaccine Delivery Device Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Teva Pharmaceuticals Company Information
 Table 76. Teva Pharmaceuticals Description and Business Overview
 Table 77. Teva Pharmaceuticals Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Pharmaceuticals Intranasal Drug And Vaccine Delivery Device Product
 Table 79. Teva Pharmaceuticals Recent Developments/Updates
 Table 80. Aptar Pharma Company Information
 Table 81. Aptar Pharma Description and Business Overview
 Table 82. Aptar Pharma Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Aptar Pharma Intranasal Drug And Vaccine Delivery Device Product
 Table 84. Aptar Pharma Recent Developments/Updates
 Table 85. UCB Company Information
 Table 86. UCB Description and Business Overview
 Table 87. UCB Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. UCB Intranasal Drug And Vaccine Delivery Device Product
 Table 89. UCB Recent Developments/Updates
 Table 90. Teleflex Company Information
 Table 91. Teleflex Description and Business Overview
 Table 92. Teleflex Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teleflex Intranasal Drug And Vaccine Delivery Device Product
 Table 94. Teleflex Recent Developments/Updates
 Table 95. 3M Company Information
 Table 96. 3M Description and Business Overview
 Table 97. 3M Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. 3M Intranasal Drug And Vaccine Delivery Device Product
 Table 99. 3M Recent Developments/Updates
 Table 100. Bespak Company Information
 Table 101. Bespak Description and Business Overview
 Table 102. Bespak Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bespak Intranasal Drug And Vaccine Delivery Device Product
 Table 104. Bespak Recent Developments/Updates
 Table 105. OptiNose Company Information
 Table 106. OptiNose Description and Business Overview
 Table 107. OptiNose Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. OptiNose Intranasal Drug And Vaccine Delivery Device Product
 Table 109. OptiNose Recent Developments/Updates
 Table 110. Intersect Company Information
 Table 111. Intersect Description and Business Overview
 Table 112. Intersect Intranasal Drug And Vaccine Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Intersect Intranasal Drug And Vaccine Delivery Device Product
 Table 114. Intersect Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Intranasal Drug And Vaccine Delivery Device Distributors List
 Table 118. Intranasal Drug And Vaccine Delivery Device Customers List
 Table 119. Intranasal Drug And Vaccine Delivery Device Market Trends
 Table 120. Intranasal Drug And Vaccine Delivery Device Market Drivers
 Table 121. Intranasal Drug And Vaccine Delivery Device Market Challenges
 Table 122. Intranasal Drug And Vaccine Delivery Device Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intranasal Drug And Vaccine Delivery Device
 Figure 2. Global Intranasal Drug And Vaccine Delivery Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intranasal Drug And Vaccine Delivery Device Market Share by Type: 2024 & 2031
 Figure 4. Powder Delivery Device Product Picture
 Figure 5. Liquid Delivery Device Product Picture
 Figure 6. Pressurized Metered Dose Inhaler Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Intranasal Drug And Vaccine Delivery Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Intranasal Drug And Vaccine Delivery Device Market Share by Application: 2024 & 2031
 Figure 10. Respiratory Disorders
 Figure 11. Neurological Disorder
 Figure 12. Vaccination
 Figure 13. Pain Management
 Figure 14. Others
 Figure 15. Global Intranasal Drug And Vaccine Delivery Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Intranasal Drug And Vaccine Delivery Device Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Intranasal Drug And Vaccine Delivery Device Sales (2020-2031) & (K Units)
 Figure 18. Global Intranasal Drug And Vaccine Delivery Device Average Price (US$/Unit) & (2020-2031)
 Figure 19. Intranasal Drug And Vaccine Delivery Device Report Years Considered
 Figure 20. Intranasal Drug And Vaccine Delivery Device Sales Share by Manufacturers in 2024
 Figure 21. Global Intranasal Drug And Vaccine Delivery Device Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Intranasal Drug And Vaccine Delivery Device Players: Market Share by Revenue in Intranasal Drug And Vaccine Delivery Device in 2024
 Figure 23. Intranasal Drug And Vaccine Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Intranasal Drug And Vaccine Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Intranasal Drug And Vaccine Delivery Device Sales Market Share by Country (2020-2031)
 Figure 26. North America Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 27. United States Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Intranasal Drug And Vaccine Delivery Device Sales Market Share by Country (2020-2031)
 Figure 30. Europe Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Intranasal Drug And Vaccine Delivery Device Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Region (2020-2031)
 Figure 38. China Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Intranasal Drug And Vaccine Delivery Device Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Intranasal Drug And Vaccine Delivery Device Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Intranasal Drug And Vaccine Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Intranasal Drug And Vaccine Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Intranasal Drug And Vaccine Delivery Device by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Intranasal Drug And Vaccine Delivery Device by Type (2020-2031)
 Figure 59. Global Intranasal Drug And Vaccine Delivery Device Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Intranasal Drug And Vaccine Delivery Device by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Intranasal Drug And Vaccine Delivery Device by Application (2020-2031)
 Figure 62. Global Intranasal Drug And Vaccine Delivery Device Price (US$/Unit) by Application (2020-2031)
 Figure 63. Intranasal Drug And Vaccine Delivery Device Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Intranasal Drug Delivery Devices Market Insights Forecast to 2030
Global Nasal Drug Delivery Devices Market Research Report 2024
Global Inhalation and Nasal Drug Delivery Devices Market Research Report 2024
Intranasal Drug and Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intranasal Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inhalation Drug Delivery Device Market Research Report 2024
Global Intranasal Mucosal Atomization Device Market Research Report 2025
Global Spray Drug Delivery Device Market Research Report 2024
Intranasal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nasal Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intranasal Corticosteroids Market Research Report 2024
Global Nasal Irrigation Devices Market Research Report 2024
Global Aerosol Delivery System Market Research Report 2025
Global Rhinology Medical Devices Market Research Report 2024
Global Intranasal Drug Delivery Market Research Report 2024
Global Oral Mucosal Drug Delivery System Market Research Report 2024
Global Allergic Rhinitis Treatment Device Market Research Report 2024
Global Nasal Metered Spray Pump Market Research Report 2024
Nasal Spray Influenza Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Electronic Nasal Spray Device Market Research Report 2024

RELATED REPORTS

Global Clavicle Brace Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0P17042
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Drawer Freezer Rack Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17F16823
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Manual Bobath Table Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20X16760
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Abdominal Surgical Instruments Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28Y16243
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions